– USA, MN – Cirtec Medical, a global leader in design, development, and manufacturing of complex Class II and III medical devices, announced the appointment of Steven Chevillotte to its Board of Directors, effective immediately, bringing over two decades of international leadership experience spanning the life sciences, aerospace, and advanced manufacturing sectors.
About Steven Chevillotte
Known for driving growth in highly regulated, highly engineered environments, Steven has developed a strong track record in operational excellence, M&A, and post-merger integration.
He serves as CEO of SaniSure, a global leader in the design and manufacture of single-use equipment for bioprocessing. Since taking the helm in 2022, he has led initiatives to strengthen global operations, accelerate Voice-of-Customer-based innovation, and expand go-to-market strategies worldwide. Before becoming CEO, he served as CFO of SaniSure from June 2021 to June 2022.
Hi leadership background includes senior executive roles in both finance and operations. He served as CFO at Integrated Polymer Solutions and Consolidated Aerospace Manufacturing, where he played a critical role in driving revenue growth from $240 million to $400 million in under three years, culminating in the company’s successful $1.5 billion acquisition by Stanley Black & Decker.
Earlier in his career, Steven spent nearly a decade at ZEISS Surgical Ophthalmology, where he held progressively senior roles, including VP of U.S. Operations, CFO, and ultimately President of ZEISS North America. His work helped advance ZEISS’s integrated surgical platform in areas such as cataract, refractive, retina, and corneal surgery.
About Cirtec Medical
Cirtec Medical is a global leader in the design, development, and manufacturing of complex Class II and III medical devices, specializing in active implant systems, interventional devices, and precision components. Since 1987, Cirtec Medical has built extensive in-house capabilities that enable the company to serve as a single-source partner and collaborate with customers to transform their technology into innovative medical devices across a wide array of therapies, including cardiology, neurology, orthopedics, and other minimally invasive device applications. Cirtec Medical’s deep expertise in precision component design and manufacturing supports every stage of the product lifecycle, ensuring uncompromising quality and performance. With 11 global facilities and a vertically integrated approach, Cirtec Medical aims to expedite time to market, reduce risk, and accelerate revenue generation for our partners.
For more information, https://www.cirtecmed.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.